Acromegaly
188
12
12
123
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
42 trials with published results (22%)
Research Maturity
123 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
8.0%
15 terminated out of 188 trials
89.1%
+2.6% vs benchmark
28%
53 trials in Phase 3/4
34%
42 of 123 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 123 completed trials
Clinical Trials (188)
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Korean Regulatory Post Marketing Surveillance for Somavert
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
Direct Versus Video Laryngoscopy in Patients With Acromegaly
A Study to Evaluate MAR002 for Acromegaly
ACRODAT Prospective Evaluation Study
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Study of MAR002 in Healthy Men
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Reproducibility and Utility of OGTT in Acromegaly
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Effects of Pasireotide Lar Therapy on Bone Metabolism
Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly
A Prospective Study of Outcome After Therapy for Acromegaly